CNS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 237 industry peers in the Capital Markets industry. CNS scores excellent on profitability, but there are some minor concerns on its financial health. CNS does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CNS was profitable.
In the past year CNS has reported a negative cash flow from operations.
Of the past 5 years CNS 4 years were profitable.
Of the past 5 years CNS 4 years had a positive operating cash flow.

1.2 Ratios

CNS has a better Return On Assets (20.48%) than 97.48% of its industry peers.
The Return On Equity of CNS (29.83%) is better than 95.38% of its industry peers.
CNS's Return On Invested Capital of 24.24% is amongst the best of the industry. CNS outperforms 97.90% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNS is significantly above the industry average of 7.27%.
The last Return On Invested Capital (24.24%) for CNS is well below the 3 year average (28.30%), which needs to be investigated, but indicates that CNS had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	20.48%
ROE	29.83%
ROIC	24.24%

ROA(3y)20.51%

ROA(5y)25.29%

ROE(3y)38.03%

ROE(5y)48.18%

ROIC(3y)28.3%

ROIC(5y)38.19%

1.3 Margins

CNS's Profit Margin of 29.73% is fine compared to the rest of the industry. CNS outperforms 73.53% of its industry peers.
In the last couple of years the Profit Margin of CNS has declined.
CNS has a better Operating Margin (33.83%) than 65.13% of its industry peers.
In the last couple of years the Operating Margin of CNS has declined.
With an excellent Gross Margin value of 88.60%, CNS belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CNS has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	33.83%
PM (TTM)	29.73%
GM	88.6%

OM growth 3Y-9.18%

OM growth 5Y-3.03%

PM growth 3Y-6.88%

PM growth 5Y-2.25%

GM growth 3Y0.74%

GM growth 5Y0.55%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 9.23 indicates that CNS is not in any danger for bankruptcy at the moment.
The Altman-Z score of CNS (9.23) is better than 94.12% of its industry peers.
CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	9.23

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.79 indicates that CNS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.79, CNS is doing worse than 63.45% of the companies in the same industry.
CNS has a Quick Ratio of 0.79. This is a bad value and indicates that CNS is not financially healthy enough and could expect problems in meeting its short term obligations.
CNS has a worse Quick ratio (0.79) than 63.03% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.79
Quick Ratio	0.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.80% over the past year.
Measured over the past 5 years, CNS shows a small growth in Earnings Per Share. The EPS has been growing by 3.74% on average per year.

EPS 1Y (TTM)5.8%

EPS 3Y-5.81%

EPS 5Y3.74%

EPS Q2Q%3.85%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-5.55%

3.2 Future

The Earnings Per Share is expected to grow by 8.66% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.70% on average over the next years.

EPS Next Y8.49%

EPS Next 2Y8.3%

EPS Next 3Y8.22%

EPS Next 5Y8.66%

Revenue Next Year8.33%

Revenue Next 2Y7.78%

Revenue Next 3Y7.24%

Revenue Next 5Y6.7%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CNS is valuated rather expensively with a Price/Earnings ratio of 21.26.
Compared to the rest of the industry, the Price/Earnings ratio of CNS indicates a slightly more expensive valuation: CNS is more expensive than 60.92% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.21. CNS is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 19.60, which indicates a rather expensive current valuation of CNS.
The rest of the industry has a similar Price/Forward Earnings ratio as CNS.
CNS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.98.

		Industry Rank	Sector Rank
PE	21.26
Fwd PE	19.6

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNS is valued a bit cheaper than 78.57% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	16.46

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNS does not grow enough to justify the current Price/Earnings ratio.
CNS has a very decent profitability rating, which may justify a higher PE ratio.

PEG (NY)2.5

PEG (5Y)5.68

EPS Next 2Y8.3%

EPS Next 3Y8.22%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.61%, CNS has a reasonable but not impressive dividend return.
CNS's Dividend Yield is comparable with the industry average which is at 5.87.
CNS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.

		Industry Rank	Sector Rank
Dividend Yield	3.61%

5.2 History

The dividend of CNS decreases each year by -7.12%.
CNS has paid a dividend for at least 10 years, which is a reliable track record.
CNS has decreased its dividend in the last 3 years.

Dividend Growth(5Y)-7.12%

Div Incr Years2

Div Non Decr Years2

5.3 Sustainability

76.25% of the earnings are spent on dividend by CNS. This is not a sustainable payout ratio.

DP76.25%

EPS Next 2Y8.3%

EPS Next 3Y8.22%

More info and screens

Find the best dividend stocks

Show peers with best dividend

COHEN & STEERS INC / CNS FAQ

What is the ChartMill fundamental rating of COHEN & STEERS INC (CNS) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CNS.

What is the valuation status for CNS stock?

ChartMill assigns a valuation rating of 2 / 10 to COHEN & STEERS INC (CNS). This can be considered as Overvalued.

Can you provide the profitability details for COHEN & STEERS INC?

COHEN & STEERS INC (CNS) has a profitability rating of 7 / 10.

Can you provide the financial health for CNS stock?

The financial health rating of COHEN & STEERS INC (CNS) is 5 / 10.

What is the expected EPS growth for COHEN & STEERS INC (CNS) stock?

The Earnings per Share (EPS) of COHEN & STEERS INC (CNS) is expected to grow by 8.49% in the next year.